Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Thom

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Stroke|September 13, 2003
Protein Z in ischemic stroke and its etiologic subtypesAndrew M McQuillan, John W Eikelboom, Graeme J Hankey, et al.
Thrombosis and Haemostasis|March 28, 2002
A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentratesEmmanuel J Favaloro, Melinda Bukuya, Teresa Martinelli, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 9, 2009
Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand diseaseEmmanuel J Favaloro, Jim Thom, David Patterson, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|July 19, 2005
Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error ratesEmmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, et al.
American Heart Journal|December 17, 2008
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) TrialGerald Yong, Jamie Rankin, Louise Ferguson, et al.
Circulation|October 8, 2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular riskJohn W Eikelboom, Graeme J Hankey, Jim Thom, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Stroke|September 13, 2003
Protein Z in ischemic stroke and its etiologic subtypesAndrew M McQuillan, John W Eikelboom, Graeme J Hankey, et al.
Thrombosis and Haemostasis|March 28, 2002
A comparative multi-laboratory assessment of three factor VIII/von Willebrand factor concentratesEmmanuel J Favaloro, Melinda Bukuya, Teresa Martinelli, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 9, 2009
Potential supplementary utility of combined PFA-100 and functional von Willebrand factor testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand diseaseEmmanuel J Favaloro, Jim Thom, David Patterson, et al.
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|July 19, 2005
Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error ratesEmmanuel J Favaloro, Roslyn Bonar, Geoff Kershaw, et al.
American Heart Journal|December 17, 2008
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) TrialGerald Yong, Jamie Rankin, Louise Ferguson, et al.
Circulation|October 8, 2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular riskJohn W Eikelboom, Graeme J Hankey, Jim Thom, et al.
Pageof 2